Table 1 Demographics, predisposing factors to infection and infectious history

Male (n (%))

23 (85.2)

Age, year (mean ± SD)

62 ± 15

 Diabetes mellitus (n (%))

12/27 (44.4)

 Hypertension (n (%))

18/26 (69.2)

 Cardiovascular disease (n (%))

13/25 (52.0)

 Active or former smokers (n (%))

11/25 (44.0)

 Alcoholism (n (%))

9/24 (37.5)

 Liver cirrhosis (n (%))

2/22 (9.1)

 Immunosuppressive drug (n (%))

1/27 (3.7)

Staphylococcus (n (%))

21 (77.8)

  MRSA (n (%))

4 (14.8)

  MSSA (n (%))

16 (59.3)

Staphylococcus haemolyticus (n (%))

1 (3.7)

Morganella morganii (n (%))

2 (7.4)

Streptococcus oralis (n (%))

1 (3.7)

ESBL-producing Escherichia coli (n (%))

1 (3.7)

Enterococcus faecalis (n (%))

1 (3.7)

Enterobacteraerogenes (n (%))

1 (3.7)

Chlamydia pneumoniae (n (%))

1 (3.7)

Corynebacterium amycolatum (n (%))

1 (3.7)

Dermabacter hominis (n (%))

1 (3.7)

  More than one pathogen (n (%))

7 (25.9)

  Unknown (n (%))

3 (11.1)

 Bone and joint infection (n (%))

12 (44.4)

 Skin infection (n (%))

11 (40.7)

 Bacteremia (n (%))

11 (40.7)

 Other sites

  Prosthesis, plate osteosynthesis or implantable venous access port (n (%))

5 (18.5)

  Endocarditis (n (%))

4 (14.8)

  Pneumonia (n (%))

4 (14.8)

  Urinary tract infection (n (%))

3 (11.1)